[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.185.157. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1984

Multiple Myeloma-Reply

Author Affiliations

Minneapolis

Arch Intern Med. 1984;144(4):868. doi:10.1001/archinte.1984.00350160233050
Abstract

In Reply.  —Craig and Powell have provided convincing evidence that patients with multiple myeloma and light chain proteinuria are at risk for renal insufficiency from NSAID, most likely on the basis of overt or occult light chain nephropathy. Prostaglandins are involved in the compensatory response to renal injury or reduced renal mass from many causes, as we have recently discussed elsewhere.1 As noted by Craig and Powell, and illustrated by their case report, the risk in patients with myeloma is usually multifactorial (on the basis of advanced age, other medications, and so on).Whether or not all patients with multiple myeloma are at risk for renal insufficiency from NSAID is open to question. The experience with systemic lupus erythematosus, a systemic disease with renal involvement in

First Page Preview View Large
First page PDF preview
First page PDF preview
×